Bax and Bcl-2 protein expression in gastric precancerous lesions: Immunohistochemical study

被引:21
|
作者
Anagnostopoulos, GK
Stefanou, D
Arkoumani, E
Sakorafas, G
Pavlakis, G
Arvanitidis, D
Tsianos, E
Agnantis, NJ
机构
[1] Hellen AF & Vet Gen Hosp 251, Gastroenterol Clin, Athens, Greece
[2] Hellen AF & Vet Gen Hosp 251, Dept Surg, Athens, Greece
[3] Hellen AF & Vet Gen Hosp 251, Dept Oncol, Athens, Greece
[4] Univ Hosp Ioannina, Sch Med, Gastroenterol Clin, Athens, Greece
[5] Univ Hosp Ioannina, Sch Med, Dept Pathol, Athens, Greece
关键词
apoptosis; Bax; Bcl-2; gastric; premalignant;
D O I
10.1111/j.1440-1746.2005.04057.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and Aims: Bcl-2 protein prolongs cell survival in the face of classical apoptotic stimuli, and is considered to be a suppressor of apoptosis. Bax plays a key role in apoptosis by accelerating cell death after an apoptotic stimulus. The aim of our study was to determine the roles of the Bax proapoptotic gene and the Bcl-2 antiapoptotic gene in the carcinogenesis of gastric cancer. Methods: One hundred and forty-five gastric biopsy specimens of chronic gastritis, atrophic gastritis, intestinal metaplasia and gastric dysplasia were studied. Using immunohistochemical methods, Bax and Bcl-2 protein expression was observed. Results: Bax was expressed in epithelial cells in all cases of chronic gastritis. Bax was not detected in 26% of specimens of atrophic gastritis. As intestinal metaplasia develops, Bax is further suppressed. In biopsy samples with dysplasia, Bax expression was demonstrated only in 12% of biopsy samples. Although Bcl-2 protein was not detected in chronic gastritis, aberrant expression was found in gastric epithelial intestinal metaplasia and dysplasia. Conclusions: The suppression of Bax and overexpression of Bcl-2 protein is an early event in gastric tumorigenesis, before gastric dysplastic changes occur. (C) 2005 Blackwell Publishing Asia Pty Ltd.
引用
收藏
页码:1674 / 1678
页数:5
相关论文
共 50 条